LIMITED PROTECTION AGAINST IRON-INDUCED LIPID-PEROXIDATION BY CORD BLOOD-PLASMA

被引:47
作者
LINDEMAN, JHN
HOUDKAMP, E
LENTJES, EGWM
POORTHUIS, BJHM
BERGER, HM
机构
[1] UNIV HOSP LEIDEN, DEPT PEDIAT, NEONATAL UNIT, POB 9600, 2300 RC LEIDEN, NETHERLANDS
[2] LEIDEN UNIV HOSP, DEPT CLIN CHEM, 2333 AA LEIDEN, NETHERLANDS
来源
FREE RADICAL RESEARCH COMMUNICATIONS | 1992年 / 16卷 / 05期
关键词
NEWBORN; TRANSFERRIN; CERULOPLASMIN; BLEOMYCIN-DETECTABLE IRON; LIPID PEROXIDATION;
D O I
10.3109/10715769209049181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ability of plasma from newborn babies (cord blood) and adults to inhibit iron-induced lipid peroxidation was compared. The caeruloplasmin and transferrin concentrations, and latent iron-binding capacity were lower in the babies (p < 0.001). The plasma of many of the babies had no latent iron-binding capacity and contained non-protein-bound iron (measured by the bleomycin assay). The in vitro ability of plasma to inhibit iron-induced liposome peroxidation by either ferroxidase antioxidant activity (caeruloplasmin) or iron-binding antioxidant activity (transferrin) was measured. The antioxidant activity in both assays was decreased in the babies (p < 0.001). The percentage inhibiton of peroxidation in the iron-binding antioxidant assay correlated positively with the latent iron-binding capacity (p < 0.001) and negatively with the presence of bleomycin-detectable iron (p < 0.02) in the babies. This assay produced stimulation of peroxidation in 42% of the babies but none of the adults. The diminished capacity of cord blood plasma to prevent iron-induced lipid peroxidation may predispose the newborn baby to the toxic effects of oxygen. © 1992 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:285 / 294
页数:10
相关论文
共 40 条
[12]  
GUTTERIDGE JMC, 1985, CRC HDB METHODS OXYG, P391
[13]  
GUTTERIDGE JMC, 1989, CLIN HAEMATOL, V2, P195
[14]   CERULOPLASMIN LEVELS AND ERYTHROCYTE SUPEROXIDE-DISMUTASE ACTIVITY IN SMALL PRETERM INFANTS DURING THE EARLY ANEMIA OF PREMATURITY [J].
HAGA, P ;
KRAN, S .
ACTA PAEDIATRICA SCANDINAVICA, 1981, 70 (06) :861-864
[15]   CENTRAL NERVOUS-SYSTEM TRAUMA AND STROKE .2. PHYSIOLOGICAL AND PHARMACOLOGICAL EVIDENCE FOR INVOLVEMENT OF OXYGEN RADICALS AND LIPID-PEROXIDATION [J].
HALL, ED ;
BRAUGHLER, JM .
FREE RADICAL BIOLOGY AND MEDICINE, 1989, 6 (03) :303-313
[16]   THE ANTIOXIDANTS OF HUMAN EXTRACELLULAR FLUIDS [J].
HALLIWELL, B ;
GUTTERIDGE, JMC .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1990, 280 (01) :1-8
[17]   BLEOMYCIN-DETECTABLE IRON IN SERUM FROM LEUKEMIC PATIENTS BEFORE AND AFTER CHEMOTHERAPY - THERAPEUTIC IMPLICATIONS FOR TREATMENT WITH OXIDANT-GENERATING DRUGS [J].
HALLIWELL, B ;
ARUOMA, OI ;
MUFTI, G ;
BOMFORD, A .
FEBS LETTERS, 1988, 241 (1-2) :202-204
[18]   NON-TRANSFERRIN PLASMA IRON [J].
HERSHKO, C ;
PETO, TEA .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (02) :149-151
[19]   NONSPECIFIC SERUM IRON IN THALASSEMIA - ABNORMAL SERUM IRON FRACTION OF POTENTIAL TOXICITY [J].
HERSHKO, C ;
GRAHAM, G ;
BATES, GW ;
RACHMILEWITZ, EA .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (02) :255-263
[20]  
Karp W B, 1986, Adv Pediatr, V33, P127